We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Big or Small, FDA Wants to Hear About All Trial-Related AEs
Big or Small, FDA Wants to Hear About All Trial-Related AEs
April 27, 2012
Trial sponsors should notify the FDA about all adverse events brought to their attention by data monitoring committees (DMC), regardless of whether the safety issue is “serious” or not, according to an agency guidance.